Alessandra Larocca, MD, PhD is a hematologist at the Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Italy. She studied Medicine at the University of Milano, and completed her residency in Hematology at the same institution. In 2014 she obtained her PhD in Pathology and Experimental Oncology at the University of Torino. She is involved in the design, development and coordination of phase I/II/III clinical trials for the treatment of multiple myeloma in tight collaboration with the European Myeloma Network (EMN and EMN Research Italy) and the Gruppo Italiano Malattie Ematologiche dell’Adulto (GIMEMA). She is currently local principal investigator in several multi-center clinical trials. Dr. Larocca’s main research focuses on the diagnosis and the clinical and experimental treatment of patients with multiple myeloma and associated disorders, particularly of elderly/frail patients. Her interests also include the use of new biological molecules, monoclonal antibodies, immunotherapeutic agents, CAR T Cells and stem-cell transplantation techniques. She is a member of EMN, EHA and ASH. She is author and co-author of several papers published in peer reviewed journals.